Sarah Cannon Research Institute’s Post

Entia's UKCA approval continues to make waves, being featured in Oncology News Today! In the article, Professor Peter Schmid, Chair of Cancer Medicine at St Barts Cancer Institute (Queen Mary University of London) shares his insights on #Liberty: "With Liberty, Entia has developed a practical solution that addresses some of the biggest challenges we face in treating an increasing number of people with cancer. Our clinics are getting busier, and implementing technologies like this would allow us to manage people more comfortably at home, improve their experience of care, and potentially reduce the severity and occurrence of treatment side effects. Plus, by improving clinic capacity, we can streamline services to free up time for our clinical teams and plan treatments more efficiently. It’s an amazing approach." Read the full article below: 👇 https://lnkd.in/ekDs-99t #Entia #CancerCare #Innovation #Liberty #BBCBreakingNews #HealthTech #Oncology #UKCAApproval

Targeted Oncology Palliative Care Enhances Quality of Life for Patients With Cancer December 26, 2023 Author: Nichole Tucker Palliative medicine continues to be a vital part of oncology care. According to Michelle M. Issac, MD, palliative care exists to help prolong the lives of patients with advanced illnesses as well as improve their quality-of-life. The work of palliative care professionals in cancer involves close collaboration with oncologists. In an interview with Targeted Oncology™, Issac, palliative care physician, Miami Cancer Institute, discussed the goals of both palliative care and oncology care professionals as they support patients with cancer. https://lnkd.in/gXZRNqbM

🌟 Incredible Medical Breakthrough at Hadassah! 🌟 In a groundbreaking moment, a breast cancer drug has emerged as a potential game-changer for advanced lung cancer patients at Hadassah Medical Center. 🎉 When faced with a life-threatening case of acute #hypoglycemia, Hadassah's doctors took a bold step that led to an astonishing outcome. 🏥💡 Discover how their resourcefulness and a drug called #Alpelisib turned the tide, marking a remarkable scientific milestone. 🧪🔬 Read the full story in the Israel21c article. 📚 #HadassahHeroes #MedicalInnovation #ScientificBreakthrough #CancerResearch #Hadassah #hadassahinternational #cancer #lungcancer #breastcancer Hadassah International Hadassah Medical Center Dr. Matan Fischer Prof. Gil Leibowitz Lev Prof. avivit cahn https://lnkd.in/dvtmSEEV

CAR-T: We've been hearing about CAR-T for well over a decade and it continues to make headlines - both good and questionable. It is not a one-size fits all, nor has it been approved for all blood cancers including mine, chronic lymphocytic leukemia (CLL). Did the FDA's recent black box warning overstate its risks? Here's a great read regarding the potential benefits of CAR T-cell therapies still far outweighing the risks by Mikkael A. Sekeres, MD, MS, Chief Division of Hematology and professor of medicine, Sylvester Comprehensive Cancer Center, University of Miami.  #CAR-T #bloodcancer #blackboxwarning #patientadvocacy #patientsafety #cll #mutliplemyeloma #MDS

Thyroid cancer, though relatively uncommon compared to other forms of cancer, can have a significant impact on individuals of all ages #VentureCure | #cancercare | #cancermedicine | #healthsolution https://lnkd.in/ewsGRhmx

🌐RADIOTHERAPY NEWS🌐 Cases of colorectal cancer are increasing in sub-Saharan Africa, but not a lot is known about treatment and survival. This study found that due to multiple factors "there is an urgent need for significant efforts to improve cancer therapy" 👉 https://lnkd.in/gmd6AitR #radonc #RT #CancerCare #CancerCare4All National Comprehensive Cancer Network® (NCCN®)

Liver Cancer: What patients should know about #Cancer #CancerCare #CancerTreatment #ClinicalTrials #LiverCancer #OncoDaily #Oncology #PatientInformation